Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Display apparatus having a semi-penetration layer and a sealing unit
Drive apparatus
Plants and seeds of hybrid corn variety CH514730
Apparatus and method for discharging capacitor of input filter of power supply, and power supply including the apparatus
Autobrake and decel control built-in test equipment
Adding co-users to user definable co-user lists
Fast carrier allocation in multi-carrier systems
  Randomly Featured Patents
Portable original reading apparatus
Y-branch-based thermo-optic digital optical switches and variable optical attenuators with non-uniform heating
Lamp base
Card printer printhead mounting
Recording medium having recorded thereon coded information using plus and/or minus rounding of images
Portable power source to provide power to an electronic device via an interface
Apparatus for vibrating and dewebbing tire cord fabric coated with an undried liquid
Switchable mode traction control method for vehicle
Sampling device for isokinetic sampling
Display processing apparatus for image information